Dr. Arshad Khanani, MD
Claim this profileSierra Eye Associates
Studies Age-Related Macular Degeneration
Studies Cystoid Macular Edema
6 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Arshad Khanani, MD is currently running
EXG102-031
for Wet Age-Related Macular Degeneration
In neovascular (wet) age-related macular degeneration (nAMD), the macula, or the part of the eye that provides the clear, detailed central vision, is being affected by abnormal blood vessel growth and leakage. This leakage affects the vision over time and can lead to severe blurriness or blinding. EXG102-031 was made to block the extra vessel formation which would lead to less leakage affecting the vision. Before EXG102-031 can be tested for its efficacy (if it makes vision better), it must be tested to see if it is safely tolerated to confirm it can continue to be studied in more patients with nAMD.
Recruiting1 award Phase 1
OCS-01 Eye Drops
for Macular Edema
The primary objective is to evaluate the efficacy and safety of OCS 01 as compared to Vehicle in subjects with Diabetic Macular Edema (DME).
Recruiting1 award Phase 3
More about Arshad Khanani, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Arshad Khanani, MD has experience with
- 4D-150 IVT
- Dexamethasone Ophthalmic Suspension (OCS-01)
- EXG102-031
- Aflibercept IVT
- Recens Cooling Anesthesia Device
- Aflibercept
Breakdown of trials Arshad Khanani, MD has run
Age-Related Macular Degeneration
Cystoid Macular Edema
Edema
Diabetic Macular Edema
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Arshad Khanani, MD specialize in?
Arshad Khanani, MD focuses on Age-Related Macular Degeneration and Cystoid Macular Edema. In particular, much of their work with Age-Related Macular Degeneration has involved treating patients, or patients who are undergoing treatment.
Is Arshad Khanani, MD currently recruiting for clinical trials?
Yes, Arshad Khanani, MD is currently recruiting for 4 clinical trials in Reno Nevada. If you're interested in participating, you should apply.
Are there any treatments that Arshad Khanani, MD has studied deeply?
Yes, Arshad Khanani, MD has studied treatments such as 4D-150 IVT, Dexamethasone ophthalmic suspension (OCS-01), EXG102-031.
What is the best way to schedule an appointment with Arshad Khanani, MD?
Apply for one of the trials that Arshad Khanani, MD is conducting.
What is the office address of Arshad Khanani, MD?
The office of Arshad Khanani, MD is located at: Sierra Eye Associates, Reno, Nevada 89502 United States. This is the address for their practice at the Sierra Eye Associates.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.